Commercial insurance delays direct‐acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients
Torabi, Julia, Rocca, Juan P., Ajaimy, Maria, Melvin, Jeffrey, Campbell, Alesa, Akalin, Enver, Liriano, Luz E., Azzi, Yorg, Pynadath, Cindy, Greenstein, Stuart M., Le, Marie, Goldstein, Doctor Y., Fox, Amy S., Carrero, Jin, Weiss, Jeffrey M., Powell, Tia, Racine, Andrew D., Reinus, John F., Kinkhabwala, Milan M., Graham, Jay A.
Published in Transplant infectious disease (01.02.2021)
Published in Transplant infectious disease (01.02.2021)
Get full text
Journal Article
Hepatitis C Virus Positivity Should Not Be Included in the Kidney Donor Profile Index Calculation When Transplanting HCV-Positive Kidneys Into Noninfected Recipients in the Era of Direct-Acting Antiviral Agents
Graham, Jay A, Ajaimy, Maria, Carrero, Jin, Jones, Tim, Torabi, Julia, Alani, Omar, Akalin, Enver, Rocca, Juan P
Published in Progress in transplantation (Aliso Viejo, Calif.) (01.12.2019)
Published in Progress in transplantation (Aliso Viejo, Calif.) (01.12.2019)
Get more information
Journal Article